Seth M Pollack Selected Research

Seth M Pollack Research Topics

Disease

35	Neoplasms (Cancer) 04/2024 - 01/2011
34	Sarcoma (Soft Tissue Sarcoma) 04/2024 - 01/2011
11	Synovial Sarcoma (Synovioma) 03/2024 - 01/2016
11	Testicular Neoplasms (Testicular Cancer) 01/2022 - 01/2011
7	Myxoid Liposarcoma 03/2024 - 09/2012
6	Leiomyosarcoma 01/2022 - 08/2014
4	Chondrosarcoma 04/2022 - 01/2012
4	Liposarcoma 01/2022 - 02/2015
3	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 01/2016 - 05/2013
2	Melanoma (Melanoma, Malignant) 01/2022 - 02/2012
2	Adenocarcinoma 07/2019 - 01/2014
2	Adenosarcoma of the uterus 02/2014 - 06/2013
2	Non-Hodgkin Lymphoma (Lymphosarcoma) 02/2010 - 02/2009
1	Glioma (Gliomas) 02/2023
1	Cardiomyopathies (Cardiomyopathy) 01/2023
1	Osteosarcoma (Osteogenic Sarcoma) 04/2022
1	Necrosis 01/2022
1	Disease Progression 01/2021
1	Myocarditis (Carditis) 01/2020
1	Pancreatic Neoplasms (Pancreatic Cancer) 07/2019
1	Inflammation (Inflammations) 01/2019
1	Hemangioma (Angioma) 01/2018
1	Breast Neoplasms (Breast Cancer) 01/2018
1	Neutropenia 01/2018
1	Fatigue 01/2018
1	Leukopenia 01/2018
1	Anemia 01/2018
1	Leiomyoma (Uterine Fibroids) 11/2016
1	Adenosarcoma 06/2013
1	Rupture 02/2013
1	Liver Abscess 01/2013
1	Hemorrhage 10/2012
1	Neoplasm Metastasis (Metastasis) 10/2012

Drug/Important Bio-Agent (IBA)

14	AntigensIBA 01/2022 - 01/2011
7	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2023 - 10/2012
6	T-Cell Antigen Receptors (T-Cell Receptor)IBA 03/2024 - 09/2017
6	AnthracyclinesIBA 03/2024 - 02/2015
5	VaccinesIBA 11/2020 - 09/2012
4	Neoplasm Antigens (Tumor Antigens)IBA 02/2023 - 01/2014
4	Immune Checkpoint InhibitorsIBA 12/2022 - 10/2018
4	TrabectedinIBA 03/2022 - 06/2013
3	pembrolizumabIBA 01/2021 - 01/2018
3	pazopanib FDA Link 01/2016 - 01/2013
2	Ifosfamide FDA LinkGeneric 03/2024 - 01/2020
2	B7-H1 AntigenIBA 01/2022 - 09/2017
2	Chimeric Antigen ReceptorsIBA 01/2022 - 01/2022
2	olaratumabIBA 01/2020 - 01/2020
2	NivolumabIBA 01/2020 - 01/2018
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2020 - 01/2018
2	Phosphotransferases (Kinase)IBA 10/2018 - 02/2013
2	ParaffinIBA 09/2017 - 09/2012
2	Angiogenesis InhibitorsIBA 08/2017 - 01/2013
2	Imatinib Mesylate (Gleevec)FDA Link 01/2016 - 01/2013
1	HLA-A Antigens (HLA-A)IBA 03/2024
1	Toll-Like Receptor 4IBA 10/2023
1	bafilomycin A1IBA 02/2023
1	ErbB Receptors (EGF Receptor)IBA 02/2023
1	epidermal growth factor receptor VIIIIBA 02/2023
1	Verteporfin (Visudyne)FDA Link 02/2023
1	2-bromolysergic acid diethylamide (BOL)IBA 01/2023
1	atezolizumabIBA 01/2022
1	avelumabIBA 01/2022
1	CytokinesIBA 01/2022
1	Interleukin-15 (Interleukin 15)IBA 01/2021
1	Proteins (Proteins, Gene)FDA Link 01/2021
1	Recombinant ProteinsIBA 11/2020
1	Mesna (Coenzyme M)FDA LinkGeneric 01/2020
1	Antineoplastic Agents (Antineoplastics)IBA 01/2020
1	Interferon-gamma (Interferon, gamma)IBA 01/2020
1	Biomarkers (Surrogate Marker)IBA 01/2020
1	Amino Acids FDA Link 07/2019
1	InterferonsIBA 01/2019
1	tyrosine receptor (receptor, tyrosine)IBA 10/2018
1	eribulin FDA Link 01/2018
1	Propranolol (Inderal)FDA LinkGeneric 01/2018
1	Adrenergic Receptors (Adrenergic Receptor)IBA 01/2018
1	Formaldehyde (Formol)FDA Link 09/2017
1	AutoantigensIBA 09/2017
1	Apoptosis Regulatory ProteinsIBA 09/2017
1	Programmed Cell Death 1 ReceptorIBA 09/2017
1	regorafenibIBA 01/2016
1	Tyrosine Kinase InhibitorsIBA 01/2016
1	Alkylating AgentsIBA 02/2015
1	Aurora Kinase AIBA 08/2014
1	Interleukin-17 (Interleukin 17)IBA 01/2014
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2013

Therapy/Procedure

32	Therapeutics 03/2024 - 01/2011
16	Immunotherapy 04/2024 - 01/2011
11	Drug Therapy (Chemotherapy) 03/2024 - 02/2010
3	Radiotherapy 04/2024 - 04/2022
2	Neoadjuvant Therapy 01/2022 - 01/2014
2	Hematopoietic Stem Cell Transplantation 02/2010 - 02/2009
1	Radioimmunotherapy 04/2024
1	Immunomodulation 10/2023
1	Intravenous Infusions 01/2023
1	Intravenous Administration 01/2020
1	Operative Surgical Procedures 11/2016
1	Cholecystectomy 11/2016
1	Hysterectomy 11/2016
1	Radiofrequency Ablation 05/2013